Verastem Oncology prices USD 250 million common stock, pre-funded warrant offering

Bitget2026/10/14 10:04

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Verastem priced an underwritten follow-on offering of 30,937,500 common shares at USD 8.00 per share.
Deal includes pre-funded warrants for 312,503 shares at USD 7.9999 each, with a USD 0.0001 exercise price.
Gross proceeds expected to total about USD 250 million, before fees.
Closing targeted for about Oct. 15, 2026, subject to customary conditions.
Net proceeds earmarked for clinical development, including the VS-7375 program, working capital, and general corporate purposes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Verastem Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261014594734) on October 14, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Verastem Oncology prices USD 250 million common stock, pre-funded warrant offering

You may also like

Crypto prices